“…When performing in vitro biocatalytic processes, several factors such as cost, solubility, instability, or restricted activity of cofactors may impede further development of enzymes ( Paul et al., 2014 ; Paul and Hollmann, 2016 ; Guarneri et al., 2019 ). Shorter versions of NADH, varying substituents on the dihydropyridine ring and nitrogen ( Figure 2 A), were synthesized and used as cofactor biomimetics with oxidoreductase enzymes to catalyze the reduction of carbon-carbon double bonds ( Paul et al., 2013 ; Löw et al., 2016 ; Knaus et al., 2016 ; Falcone et al., 2019 ), the hydroxylation of benzoates ( Ryan et al., 2008 ; Guarneri et al., 2020 ), or the oxidation of glucose ( Nowak et al., 2017 ; Huang et al., 2019 ). These nicotinamide cofactor biomimetics allow for an orthogonal system when using enzymes as cell-free extracts for the reduction of carbon-carbon double bonds: activity by other oxidoreductases such as alcohol dehydrogenases was excluded, as these enzymes do not function with those truncated cofactors ( Josa-Culleré et al., 2019 ; Paul et al., 2013 ).…”